These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11854123)

  • 1. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
    Skudicky D; Sareli P; Libhaber E; Candy G; Radevski I; Valtchanova Z; Tshele E; Thijs L; Wang JG; Staessen JA
    Circulation; 2002 Feb; 105(7):830-6. PubMed ID: 11854123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
    Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
    Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
    Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy.
    Boström PA; Mansour P; Diemer H; Mattiasson I; Nehoum A; Lilja B; Berglund G
    J Hum Hypertens; 1995 Dec; 9(12):969-74. PubMed ID: 8746641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study.
    Mengesha HG; Welegerima AH; Hadgu A; Temesgen H; Otieno MG; Tsegay K; Fisseha T; Getachew S; Merha Z; Tewodros H; Dabessa J; Gebreegzabher B; Petrucka P
    PLoS One; 2018; 13(9):e0203166. PubMed ID: 30204768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
    Dahlöf B; Hansson L
    J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension].
    Ostroumova OD; Kochetkov AI
    Kardiologiia; 2016 Dec; 56(11):27-37. PubMed ID: 28290816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
    Asmar R; Garcia-Puig J; Gosse P; Karpov YA; De Leeuws PW; Magometschniggs D; Matos L; Schmieder R
    Vasc Health Risk Manag; 2007; 3(4):371-80. PubMed ID: 17969366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.
    Mancia G; Zanchetti A; Agabiti-Rosei E; Benemio G; De Cesaris R; Fogari R; Pessina A; Porcellati C; Rappelli A; Salvetti A; Trimarco B
    Circulation; 1997 Mar; 95(6):1464-70. PubMed ID: 9118514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
    Koldas L; Ayan F; Ikitimur B
    Jpn Heart J; 2003 Sep; 44(5):693-704. PubMed ID: 14587651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
    Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage.
    Parati G; Ulian L; Sampieri L; Palatini P; Villani A; Vanasia A; Mancia G
    Hypertension; 2000 Feb; 35(2):614-20. PubMed ID: 10679506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.